ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

Zerhouni Appoints Two Institute Directors

September 13, 2002

Cancer Control Grows Up Fast As It Moves To Meet Mandate, Take Over Big Part Of NCI Budget

March 15, 1974

Wiernik Loses Post At Einstein Following Unauthorized Trials

November 5, 1993

Concept Approval Given To $7 Million In OD Recompetitions, Renewals

May 28, 1982

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011